Notably, Ketorolac also caused down-regulation of VEGF at transcript and protein levels and significant upregulation of E-cadherin at the transcript levels indicative of its ability to prevent cellular migration and metastasis which is one of the major unmet need in RCC. Here, VEGFA is linked to renal cell carcinoma.